ID: ALA5268811

Max Phase: Preclinical

Molecular Formula: C20H26N2O

Molecular Weight: 310.44

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NCC2CCN(Cc3ccccc3)CC2)cc1

Standard InChI:  InChI=1S/C20H26N2O/c1-23-20-9-7-19(8-10-20)21-15-17-11-13-22(14-12-17)16-18-5-3-2-4-6-18/h2-10,17,21H,11-16H2,1H3

Standard InChI Key:  MODXTBIKOSPADE-UHFFFAOYSA-N

Associated Targets(Human)

Acetylcholinesterase 18204 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-secretase 1 15641 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 310.44Molecular Weight (Monoisotopic): 310.2045AlogP: 4.02#Rotatable Bonds: 6
Polar Surface Area: 24.50Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.30CX LogP: 3.50CX LogD: 1.60
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.87Np Likeness Score: -1.03

References

1. Ferreira JPS, Albuquerque HMT, Cardoso SM, Silva AMS, Silva VLM..  (2021)  Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).,  221  [PMID:33984802] [10.1016/j.ejmech.2021.113492]

Source